Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Online Network.
Corza Medical Announces the Launch of the Expanded Onatec Ophthalmic Suture Portfolio
GlobeNewswire, Inc.
·
July 7, 2025
PARSIPPANY, New Jersey, July 07, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch of its expanded Onatec Ophthalmic Suture Portfolio. This marks a significant extension of the product...
China Imposes Ban on EU Medical Device Imports
MENAFN
·
July 7, 2025
(MENAFN) China on Sunday introduced new curbs on medical device imports from the European Union, escalating tensions following recent trade measures enacted by Brussels, according to media. The Chinese Ministry of Finance stated that these actions...
Nudj Health Appoints Dr. Padmaja Patel as Chief Medical Officer to Advance Lifestyle Medicine Services
GlobeNewswire, Inc.
·
July 7, 2025
PASADENA, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Nudj Health, the leading AI-powered lifestyle medicine services company, is proud to announce the appointment of Dr. Padmaja Patel as Chief Medical Officer of Lifestyle Medicine Services. In this...
Liminatus Pharma Announces New Clinical Milestone in Pancreatic Cancer Screening with Samda Biolab and INNOCS AI
EIN Presswire
·
July 7, 2025
Liminatus Pharma, Inc (NASDAQ:LIMN) LA PALMA, CA, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- Liminatus Pharma (Nasdaq: LIMN) has announced promising new clinical results that could significantly advance early detection of pancreatic...
Juntendo University Launches Space Medicine Research Unit in Neuron-Glia Crosstalk Center Juntendo
EIN Presswire
·
July 7, 2025
TOKYO, JAPAN, July 7, 2025 /EINPresswire.com/ -- Pioneering a World-leading Fusion of Space Medicine and AI. With Astronaut Naoko Yamazaki and the AI Research Institute VRI on Board, the Initiative Aims to Revolutionize the Future of Medicine...
Immix Biopharma Announces Accelerated NEXICART-2 Clinical Trial Progress in relapsed/refractory AL Amyloidosis
GlobeNewswire, Inc.
·
July 7, 2025
– National Footprint of NEXICART-2 Trial Sites Expanded – – On track for first Biologics License Application (BLA) approved cell therapy in unaddressed orphan indication – – NEXICART-2 interim results were presented at ASCO 2025 – LOS ANGELES, CA,...
AI in Medical Imaging Market to Hit $11.25 Billion by 2033, Fueled by US & Japan Innovations
EIN Presswire
·
July 7, 2025
Deep learning, hybrid modalities, and global investments are driving 24.6% CAGR through 2033, transforming diagnostic imaging. LOS ANGELES, CA, UNITED STATES, July 7, 2025 /EINPresswire.com/ -- According to DataM Intelligence, the global AI in...
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman
GlobeNewswire, Inc.
·
July 7, 2025
SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired...
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
GlobeNewswire, Inc.
·
July 7, 2025
THE WOODLANDS, TX, July 07, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the next CEO Corner...
European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia
GlobeNewswire, Inc.
·
July 7, 2025
SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today...
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
GlobeNewswire, Inc.
·
July 7, 2025
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has...
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
GlobeNewswire, Inc.
·
July 7, 2025
Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07,...
Catheter Precision, Inc. Announces First Purchase Order From University Hospital in Rennes, France
GlobeNewswire, Inc.
·
July 7, 2025
FORT MILL, S.C., July 07, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced today...
Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire, Inc.
·
July 7, 2025
MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire’s management team will host a...
Jasper Therapeutics Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria
GlobeNewswire, Inc.
·
July 7, 2025
8 of 9 participants (89%) treated in the 240mg and 360mg single dose cohorts achieved a complete response 8 of 11 participants (73%) enrolled in the 180mg Q8W open label extension study achieved a complete response at 12 weeks Results from the...
Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States
GlobeNewswire, Inc.
·
July 7, 2025
CINCINNATI, July 07, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced it has acquired a...
BeyondSpring Publishes Human Clinical Study in Med (Cell Press) Showing Plinabulin-Driven Dendritic Cell Maturation and Tumor Response After Prior Checkpoint Inhibitor Failure
GlobeNewswire, Inc.
·
July 7, 2025
In eight tumors where patients failed immune checkpoint inhibitor (ICI) treatment, Plinabulin + radiation + PD-1 inhibitors demonstrated an overall response rate (ORR) of 23% and a disease control rate (DCR) of 54% in non-irradiated lesions....
The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region
GlobeNewswire, Inc.
·
July 7, 2025
- Proven Operator Grows to 96 Clinics and Commits to Open 10 Additional Clinics - - Sale Price Included $8.3 Million Plus Regional Developer Rights that Generated $855,000 in Royalties and Franchise Fees over the 12 Months Ended March 31, 2025 -...
Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis
GlobeNewswire, Inc.
·
July 7, 2025
APEX Part A met all primary and key secondary endpoints and exceeded trial objectives, including 71.0% decrease from baseline in EASI at Week 16 APG777 demonstrated EASI-75 of 66.9% (42.5% placebo-adjusted) at Week 16, the highest topline and...
Monarch House Expands with New Clinic in Leaside to Support Children with Autism and Developmental Exceptionalities
EIN Presswire
·
July 7, 2025
Monarch House Ltd, the leading national service provider for children with autism and developmental differences, announces the opening of Leaside, Toronto. TORONTO, ONTARIO, CANADA, July 7, 2025 /EINPresswire.com/ -- Monarch House Ltd (Monarch...